Abstract OT3-15-01: TBCRC-053: P-RAD: A Randomized Study of Preoperative Chemotherapy, Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, HER2-Negative Breast Cancer
Joseph J. Connolly(Massachusetts General Hospital), Alice Ho(Breast Cancer Research Foundation), Carey K. Anders(Duke University), Laura M. Spring(Massachusetts General Hospital), Tiffany A. Traina(Memorial Sloan Kettering Cancer Center), Ana C. Garrido-Castro(Dana-Farber Cancer Institute), Antonio C. Wolff(Johns Hopkins University), Rachel Blitzblau(Duke Medical Center), Alastair M. Thompson(Baylor College of Medicine), Elizabeth A. Mittendorf(Beth Israel Deaconess Medical Center), Ian E. Krop(Yale Cancer Center), Dana L. Casey(University of North Carolina at Chapel Hill), Elyssa N. Denault(Massachusetts General Hospital), Michele A. Gadd(Massachusetts General Hospital), Atif J. Khan(Memorial Sloan Kettering Cancer Center), Lisa K. Jacobs(Johns Hopkins University), Lisa A. Carey(University of North Carolina at Chapel Hill), José Pablo Leone(Harvard University), Alphonse G. Taghian(Massachusetts General Hospital), Tari A. King(Brigham and Women's Hospital), George Plitas(Memorial Sloan Kettering Cancer Center), E. Shelley Hwang(University of Bern), Cesar Augusto Santa-Maria(Sidney Kimmel Comprehensive Cancer Center), Yara Abdou(University of North Carolina at Chapel Hill), Gaorav P. Gupta(University of North Carolina at Chapel Hill), Jean L. Wright(University of North Carolina at Chapel Hill)
Cited by 5
Related Papers
Tumour exosome integrins determine organotropic metastasis
|Nature|2015|5.2k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k